Status:
COMPLETED
Bronchoprotection of Salbutamol in Asthma and Chronic Obstructive Pulmonary Disease
Lead Sponsor:
University of Saskatchewan
Conditions:
Asthma
COPD
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This study will investigate potential differences in how two puffs of salbutamol protects airway smooth muscle from contracting in people with asthma and chronic obstructive pulmonary disease (COPD).
Detailed Description
In asthma, the administration (inhalation) of a selective β2 receptor agonist (e.g. salbutamol), prior to methacholine challenge has been shown to shift the dose response curve to the right and "bronc...
Eligibility Criteria
Inclusion
- asthma or COPD
Exclusion
- asthma and COPD
Key Trial Info
Start Date :
February 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2010
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT00440245
Start Date
February 1 2007
End Date
July 1 2010
Last Update
March 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Saskatchewan
Saskatoon, Saskatchewan, Canada, S7N0W8